Israeli health tech and life sciences venture capital firm aMoon has teamed up with Swiss biotech giant Roche to launch a new early-stage investment program named StarFinder Digital Innovation Lab.
"The program aims at accelerating innovative diagnostic technologies from the Israeli health tech ecosystem that address global healthcare challenges," the firms announced in a joint statement.
Follow Israel Hayom on Facebook and Twitter
The collaboration, called StarFinder Lab, will focus on "identifying and cultivating disruptive AI-driven data as well as digital healthcare solutions from the agile and highly skilled Israeli health tech ecosystem," according to the statement.
Funding, mentoring and strategic support will be provided to newly-formed or existing ventures chosen for the StarFinder Lab program. Elected entrepreneurs will have "access to global expertise from Roche and aMoon to build and tailor technologies for product-market fit."
Applications for the StarFinder Lab program will open in October 2020.
"As a world-renowned digital innovation hub, Israel has robust entrepreneurial resources that can provide solutions to major challenges faced by the healthcare industry," said Dr. Yair Schindel, Co-Founder and Managing Partner at aMoon.
CEO of Roche Israel Avi Danziger said the program "offers a unique strategic partnership model from concept to global market."
This article was originally published by i24NEWS.
Subscribe to Israel Hayom's daily newsletter and never miss our top stories!
